Current Projects

Ongoing projects

• Global Phase III study with 2500 patients in 550 sites, in 60 countries
  TA: Oncology
  Our role: Global Medical Monitor and Safety Reviewer
• Global Phase III study with 480 patients in 72 sites, in 12 EU countries
  TA: Oncology
  Our role: Global Medical Monitor and Safety Reviewer
• Multinational Phase II study with 290 patients in 40 sites, in 6 European countries
  TA: Immunology
  Our role: Independent Medical Expert member of the DSMB
• Global Phase III study with 596 patients in 102 sites, in 26 countries
  TA: Oncology
  Our role: Medical Reviewer